Powder x 10 vials
Jul 22 2025 Gong et al., BMC Pulmonary Medicine, doi:10.1186/s12890-025-03824-5 Efficacy and safety of combined nebulization of unfractionated heparin, acetylcysteine, budesonide and ipratropium bromide in hospitalised patients with COVID-19 pneumonia: a randomized controlled clinical trial RCT 74 hospitalized COVID-19 pneumonia patients showing improved lung lesion absorption and oxygenation with combined nebulization of unfractionated heparin, acetylcysteine, budesonide, and ipratropium bromide
[DOI] [PubMed] [Google Scholar] 81.Jomova K., Valko M
10.1080/21655979.2022.2083822 16 ChenJ.WangY.WangS.ZhaoX.ZhaoL.WangY
USA 95 , 1309113096 (1998)
SARS-CoV-2 and its massive cytokine storm primarily compromises the lungs causing acute respiratory distress syndrome also affecting the cardiovascular system aggravating atherosclerotic lesions leading to thromboembolic events and cell and tissue death (Ryu and Shin, 2021